News | ERT

50% OF ALL NDAs SUPPORTED SINCE 2014

NEWS AND MEDIA

See what we’re up to – and what we have to say – in today’s dynamic market.

FEATURED NEWS/MEDIA

January 9, 2020
ERT Solutions Support 75% of 2019 FDA Approvals
eClinical solutions deliver critical safety, efficacy, and patient experience data to meet sponsors’ drug development goals

Share
Share
November 20, 2019
ERT Cardiac Safety Solution Surpasses 10,000th Clinical Study
Milestone achieved through high precision technology, operational excellence, and continuing innovation.

Share
Share
July 31, 2019
ERT Recognized for Innovation in Health Technology: Pittsburgh Technology Council names ERT to Tech 50
ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has been named one of the 50 most successful and innovative technology companies of the Pittsburgh region by the Pittsburgh Technology Council.

Share
Share

All NEWS/MEDIA

January 9, 2020

ERT Solutions Support 75% of 2019 FDA Approvals

eClinical solutions deliver critical safety, efficacy, and patient experience data to meet sponsors’ drug development goals

December 2, 2019

The Digital Future is Here

This article – including comments by ERT’s Matt McCarty and Dr. Prakriteswar Santikary – reviews the rapidly evolving role of digital healthcare and how companies will need to ensure they are ahead of the curve in order to benefit from the digital health phenomenon.

November 26, 2019

Enhancing Patient Engagement through eClinical Technology

Learn the steps sponsors can take to ensure patient satisfaction during clinical trials and how new technologies can improve and modernize their patient engagement strategies.

November 20, 2019

ERT Cardiac Safety Solution Surpasses 10,000th Clinical Study

Milestone achieved through high precision technology, operational excellence, and continuing innovation.

November 14, 2019

Cardiac Imaging in Oncology Trials: The Benefits of Advanced Imaging Management Systems

During oncologic drug development, clinical trial sponsors often are required to utilize imaging for monitoring cardiotoxicity. For these cardiac safety trials, as in all trials involving imaging, it matters how images are taken, how they are analyzed, and how the process is monitored.

October 17, 2019

Artificial Intelligence Gains Ground Across Healthcare

The potential for Artificial Intelligence (AI) is extensive and its adoption across the healthcare industry is accelerating. But in pharma, legacy systems, insufficient storage capacity, and poor interoperability might hold them back from leveraging its benefits during new product clinical development.

October 15, 2019

Honesty in reporting suicidal ideations and behaviors in Alzheimer’s disease, mild cognitive impairment, and dementias

To ensure patient safety, it’s important to consider the needs, abilities and propensity for honesty in reporting suicidal ideations and behaviors (SIB) among populations with compromised cognitive abilities.

October 9, 2019

Transforming Clinical Development with AI: Applications in Imaging and Performance Risk Management

Here we present how a modern data platform enables the use of AI in clinical development and review particular applications for AI in imaging and in performance/risk management, both of which can speed up clinical trials and reduce overall development costs.

September 27, 2019

ERT Named Health IT Innovator of the Year

Recognized for innovation in accelerating the clinical development of new medical treatments

September 16, 2019

ERT Expands its Commitment to Heart Health and Research

Sponsors Simon’s Heart and lends its cardiac safety technology and expertise to keep children’s hearts safe.

August 29, 2019

Evaluation of the Effect of 5 QT‐Positive Drugs on the JTpeak Interval

In this study, performed by ERT’s Dr. Borje Darpo in collaboration with industry representatives, the novel safety biomarker JTpeak was evaluated on the IQ-CSRC study ECG waveforms.

August 16, 2019

Assessing QT when Drugs have a Substantial Effect on Heart Rate

In this paper, which reviews the effects of Omadacycline on QT/QTc intervals in healthy subjects, ERT’s Dr. Borje Darpo illustrates one method for handling QT assessment for drugs with a substantial effect on heart rate.

August 5, 2019

ERT Leader Recognized by PharmaVoice for Delivering Innovation in Clinical Trial Imaging

Timothy Kulbago, Vice President, Imaging has been named one of the 100 most inspiring individuals in the life-sciences industry by PharmaVoice.

July 31, 2019

ERT Recognized for Innovation in Health Technology: Pittsburgh Technology Council names ERT to Tech 50

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has been named one of the 50 most successful and innovative technology companies of the Pittsburgh region by the Pittsburgh Technology Council.

July 29, 2019

The Rise of Modern Data Platform, Cloud Computing and AI in the Clinical Trials Industry

Read how ERT is converging Artificial Intelligence, the cloud, and modern data architecture to address the increasing data challenges faced by researchers and transforming every stage of the clinical trial process, leading to more efficient clinical development and faster times to market.

July 19, 2019

Page 1 of 10
1
2
3
...
10
→

Request A Quote

Request A Quote

NEWS AND MEDIA

FEATURED NEWS/MEDIA

ERT Solutions Support 75% of 2019 FDA Approvals

Share

ERT Cardiac Safety Solution Surpasses 10,000th Clinical Study

Share

ERT Recognized for Innovation in Health Technology: Pittsburgh Technology Council names ERT to Tech 50

Share

All NEWS/MEDIA

ERT Solutions Support 75% of 2019 FDA Approvals

The Digital Future is Here

Enhancing Patient Engagement through eClinical Technology

ERT Cardiac Safety Solution Surpasses 10,000th Clinical Study

Cardiac Imaging in Oncology Trials: The Benefits of Advanced Imaging Management Systems

Artificial Intelligence Gains Ground Across Healthcare

Honesty in reporting suicidal ideations and behaviors in Alzheimer’s disease, mild cognitive impairment, and dementias

Transforming Clinical Development with AI: Applications in Imaging and Performance Risk Management

ERT Named Health IT Innovator of the Year

ERT Expands its Commitment to Heart Health and Research

Evaluation of the Effect of 5 QT‐Positive Drugs on the JTpeak Interval

Assessing QT when Drugs have a Substantial Effect on Heart Rate

ERT Leader Recognized by PharmaVoice for Delivering Innovation in Clinical Trial Imaging

ERT Recognized for Innovation in Health Technology: Pittsburgh Technology Council names ERT to Tech 50

The Rise of Modern Data Platform, Cloud Computing and AI in the Clinical Trials Industry

Mechanisms For Improving Diabetes Patient-Provider Communication Through Optimal Use Of E-Clinical Technologies

ERT Participates in Groundbreaking, Digital Technology Research

Dr. Prakriteswar Santikary to speak at The Indian Institute of Science Alumni Association

ERT Showcases Scientific and Technological Expertise in Improving Clinical Research at DIA Annual Meeting

Clinical Trial Solutions Showcase